Parameters influencing the stealthiness of colloidal drug delivery systems

被引:597
|
作者
Vonarbourg, Arnaud [1 ]
Passirani, Catherine [1 ]
Saulnier, Patrick [1 ]
Benoit, Jean-Pierre [1 ]
机构
[1] Univ Angers, INSERM U646, Immeuble IBT, F-49100 Angers, France
关键词
complement; liposome; macrophage; nanoparticle; polyethylene oxide; protein adsorption;
D O I
10.1016/j.biomaterials.2006.03.039
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Over the last few decades, colloidal drug delivery systems (CDDS) such as nano-structures have been developed in order to improve the efficiency and the specificity of drug action. Their small size permits them to be injected intravenously in order to reach target tissues. However, it is known that they can be rapidly removed from blood circulation by the immune system. CDDS are removed via the complement system and via the cells of the mononuclear phagocyte system (NIPS), after their recognition by opsonins and/or receptors present at the cell surface. This recognition is dependent on the physicochemical characteristics of the CDDS. In this study, we will focus on parameters influencing the interactions of opsonins and the macrophage plasma membrane with the surface of CDDS, whereby parameters of the polymer coating become necessary to provide good protection. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4356 / 4373
页数:18
相关论文
共 50 条
  • [1] Colloidal Drug Delivery Systems in Vaccine Delivery
    Beg, Sarwar
    Samad, Abdus
    Nazish, Iram
    Sultana, Ruksar
    Rahman, Mahfoozur
    Ahmad, Md Zaki
    Akbar, Md
    [J]. CURRENT DRUG TARGETS, 2013, 14 (01) : 123 - 137
  • [2] Colloidal systems for CNS drug delivery
    Costantino, Luca
    Tosi, Giovanni
    Ruozi, Barbara
    Bondioli, Lucia
    Vandelli, Maria Angela
    Forni, Flavio
    [J]. NANONEUROSCIENCE AND NANONEUROPHARMACOLOGY, 2009, 180 : 35 - 69
  • [3] Novel colloidal drug delivery systems
    Westesen, K
    Bunjes, H
    Hammer, G
    Siekmann, B
    [J]. PDA JOURNAL OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY, 2001, 55 (04) : 240 - 247
  • [4] SOLID COLLOIDAL DRUG DELIVERY SYSTEMS - NANOPARTICLES
    OPPENHEIM, RC
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1981, 8 (03) : 217 - 234
  • [5] Application of novel biomaterials in colloidal drug delivery systems
    Garnett, MC
    Stolnik, S
    Dunn, SE
    Armstrong, I
    Lin, W
    Schacht, E
    Ferutti, P
    Vert, M
    Davies, MC
    Illum, L
    Davis, SS
    [J]. MRS BULLETIN, 1999, 24 (05) : 49 - 56
  • [6] Application of Novel Biomaterials in Colloidal Drug Delivery Systems
    M. C. Garnett
    S. Stolnik
    S. E. Dunn
    I. Armstrong
    Wu Lin
    E. Schacht
    P. Ferutti
    M. Vert
    M. C. Davies
    L. Illum
    S. S. Davis
    [J]. MRS Bulletin, 1999, 24 : 49 - 56
  • [7] HEPATOCYTE CULTURES FOR THE TESTING OF COLLOIDAL DRUG DELIVERY SYSTEMS
    BRAUER, A
    WOLLESEN, C
    JONES, PDE
    MULLER, RH
    [J]. ARCHIV DER PHARMAZIE, 1988, 321 (09) : 684 - 684
  • [8] Colloidal delivery systems in foods: A general comparison with oral drug delivery
    Patel, A. R.
    Velikov, K. P.
    [J]. LWT-FOOD SCIENCE AND TECHNOLOGY, 2011, 44 (09) : 1958 - 1964
  • [9] Past and future evolution in colloidal drug delivery systems
    Boyd, Ben J.
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2008, 5 (01) : 69 - 85
  • [10] Colloidal systems for drug delivery: from design to therapy
    Beija, Mariana
    Salvayre, Robert
    Lauth-de Viguerie, Nancy
    Marty, Jean-Daniel
    [J]. TRENDS IN BIOTECHNOLOGY, 2012, 30 (09) : 485 - 496